用于治疗比较的融合试验数据:单张与多张跨度桥梁:单张与多张跨度桥梁
Bonnie E Shook-Sa1, Paul N Zivich2,3, Samuel P Rosin1
1Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Statistics in medicine
|December 18, 2023
概括
新的统计方法允许在不同的临床试验中比较治疗方法,即使没有直接比较手臂. 这些桥梁估计器,特别是单跨度方法,为抗逆转录病毒疗法等治疗提供了高效和公正的疗效估计.
科学领域:
- 生物统计学 生物统计学
- 临床试验方法论 临床试验方法论
- 流行病学 流行病学
背景情况:
- 随机对照试验 (RCT) 对治疗疗效至关重要,但在直接治疗比较方面存在局限性.
- 将在单独试验中评估的治疗方法进行比较是具有挑战性的,因为潜在的种群差异会影响结果.
研究的目的:
- 引入和评估两种新的桥梁估计器,用于在不同试验中比较治疗.
- 在进行间接比较时,考虑试验群体的测量差异.
- 评估这些估计器在模拟和现实应用中的性能.
主要方法:
- 开发了两个桥梁估计器:"多跨度"估计器使用共享臂和"单跨度"估计器没有共享臂.
- 创建了一个诊断统计数据,以比较标准化共享手臂的结果.
- 进行了模拟,以评估估计者偏差和置信区间覆盖率.
- 这些估计者应用于艾滋病临床试验组 (ACTG) 320和388数据.
主要成果:
- 多跨度和单跨度估计器在识别假设下显示了最小的经验偏差和名义置信区间覆盖率.
- 单跨度估计器需要较弱的识别假设.
- 单跨度方法在模拟和对艾滋病毒数据的应用方面都更有效.
结论:
- 桥梁估计器为间接治疗比较提供了一个可行的方法,当直接比较是不可行的.
- 单跨度估计器是一个强大而有效的工具,用于在独立试验中估计治疗疗效.
- 这种方法可以为治疗决策提供信息,例如比较两种药物与四种药物的抗逆转录病毒疗法,以治疗晚期的艾滋病毒.
相关概念视频
Hazard Ratio
130
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
130
Comparing the Survival Analysis of Two or More Groups
195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195


